Assessment of trichloroethylene (TCE) exposure in murine strains genetically-prone and non-prone to develop autoimmune disease

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 44, Issue 5, 2009, Pages 443-453

  Keil, Deborah E ^a   Peden Adams, Margie M ^b,c   Wallace, Stacy ^b   Ruiz, Phillip ^d   Gilkeson, Gary S ^b,e  

^a UNIVERSITY OF NEVADA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; B6C3F1; NZBWF1; Trichloroethylene

Indexed keywords

AUTOANTIBODIES; AUTOIMMUNE DISEASE; B6C3F1; CONTROL LEVELS; DRINKING WATERS; EXPOSURE PERIODS; MOUSE STRAINS; NATURAL KILLER CELLS; NEW ZEALAND; NK CELLS; NZBWF1; SERUM LEVELS; STANDARD STRAINS; T-CELL ACTIVATIONS; T-CELLS; TIME POINTS;

ANESTHETICS; ANIMALS; ANTIGENS; BODY FLUIDS; CELL PROLIFERATION; GENETIC ALGORITHMS; PATHOLOGY; POTABLE WATER; STRAIN;

TRICHLOROETHYLENE;

ANIMALS; AUTOANTIBODIES; BODY WEIGHT; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; KILLER CELLS, NATURAL; MICE; ORGAN SIZE; SPECIES SPECIFICITY; TRICHLOROETHYLENE;

ANIMALIA; MURINAE; MUS;

EID: 60849124525     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934520902719738     Document Type: Article

References (52)

1. Kimbrough, R.D.; Mitchell, F.L.; Houk, V.N. Trichloroethylene: An update. J. Toxicol. Environ. Health. 1985, 15(3-4), 369-384.
2. U.S. Environmental Protection Agency. Trichloroethylene Hazard Summary, 2000, http://www.epa.gov/ttn/atw/hlthef/triethy.html (accessed November 7, 2008).
3. ATSDR Toxicological Profile for Trichloroethylene (update). ATSDR. Atlanta: Agency for Toxic Substances and Disease Registry, 1997. www.atsdr.cdc.gov/toxpro2.html (accessed November 7, 2008).
4. Gist, G.L.; Burg, J.R. Trichloroethylene-a review of the literature from a health effects perspective. Toxicol. Ind. Health. 1995, 11, 253-307.
5. Steinberg, A.D.; Desesso, J.M. Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene? Reg. Toxicol. Pharmacol. 1993, 18, 137-153.
6. Franco, A.; Costoya, M.A.; Roca, E. Estimating risk during showering exposure to VOCs of workers in a metal-degreasing facility. J. Toxicol. Environ. Health A. 2007, 70, 627-637.
7. Haddad, S.; Tardif, G.-C.; Tardif, R. Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes. J. Toxicol. Environ. Health A. 2006, 69, 2095-2136.
8. USEPA. Site Characterization Technologies for DNAPL Investigations. EPA 542R-04-017, 2004.
9. Mazzullo, M.; Bartoli, S.; Bonora, B.; Colacci, A.; Lattanzi, G.; Niero, A.; Silingardi, Pl; Grilli, S. In vivo and in vitro interaction of trichloroethylene with macromolecules from various organs of rat and mouse. Res. Commun. Chem. Pathol. Pharmacol. 1992, 76, 192-208.
10. Flindt-Hansen, H.; Isager, H. Scleroderma after occupational exposure to trichloroethylene and trichlorethane. Acta. Derm. Venereol. 1987, 67, 263-264.
11. Kilburn, K.H.; Warshaw, R.H. Prevalence of symptoms of systemic lupus erythematous (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ. Res. 1992, 57, 1-9.
12. Byers V.S.; Levin, A.S.; Onzonoff D.M.; Baldwin, R.W. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukemia. Cancer Immonol. Immunother. 1988, 27, 77-81.
13. Khan, M.F.; Kaphalia, B.S.; Prabhakar B.S.; Kanz M.F.; Ansari G.A. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol. Appl. Pharmacol. 1995, 134(1), 155-160.
14. Lockey, J.E.; Kelly, C.R.; Cannon, G.W.; Colby, T.V.; Aldrich, V.; Livingston, G.K. Progressive systemic sclerosis associated with exposure to trichloroethylene. Occup. Med. 1987, 29, 493-496.
15. Brasington, R.D.; Thorpe-Swenson, A.J. Systemic sclerosis associated with cutaneous exposure to solvents: case report and review of the literature, Arthritis Rheum. 1991, 34, 363-631.
16. Goon, A.T.; Lee, L.T.; Tay, Y.K.; Yosipovitch, G.; Ng, S.K.; Giam, Y.C. A case of trichloroethylene hypersensitivity syndrome, Arch. Dermatol. 2001, 137, 274-276.
17. Albert, D.A.; Albert, A.N.; Vernace, M.; Sebastian, J.K.; Hsia, E.C. Analysis of a cluster of cases of Wegener granulomatosis. J. Clin. Rhuematol. 2005, 11(4), 188-193.
18. EPA Superfund: Record of Decision (2004) Tucson International Airport Area. EPA ID: AZD980737530 09/08/2004. EPA AMD/R09-04/604.
19. EPA Superfund: Record of Decision (1988) Tucson International Airport Area. EPA ID: AZD980737530 08/22/1988. EPA ROD/R09-88/021.
20. Burrell, R.; Flaherty, D.K.; Sauers, L.J. eds. Toxicology of the Immune System: A Human Approach; Van Nostrand Reinhold Publishers: 1992; 129-133.
21. Peden-Adams, M.M.; EuDaly, J.G.; Heesemann, L.M.; Smythe, J.; Miller, J.; Gilkeson, G.S.; Keil, D.E. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. 2006, 41, 249-271.
22. Sanders, V.M.; Tucker, A.N.; White, K.L.; Kauffmann, B.M.; Hallett, P.; Carchman, R.A.; Borzelleca, J.F.; Munson, A.E. Humoral and cell-mediated immune status in mice exposed to trichloroethylene in drinking water. Toxicol. Appl. Pharmacol. 1982, 62, 358-368.
23. Blossom, S.J.; Doss, J.C.; Gilbert, K.M. Chronic exposure to trichloroethylene metabolite in autoimmune-prone MRL+/+ mice promotes immune modulation and alopecia. Toxicol. Sci. 2007, 95(2), 401-411.
24. Griffin, J.M.; Gilbert, K.M.; Lamps, L.W.; Pumford, N.R. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol. Sci. 2000, 57(2), 345-352.
25. Griffin, J.M.; Gilbert, K.M.; Pumford, N.R. Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol. Sci. 2000, 54, 384-389.
26. Griffin, J.M.; Blossom, S.J.; Jackson, S.K.; Gilbert, K.M.; Pumford, N.R. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology 2000, 46, 123-137.
27. Blossom, S.J.; Doss, J.C. Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL +/+ mice following continuous developmental and early life exposure. J. Immunotox. 2007, 4, 129-141.
28. Griffin, J.M.; Gilbert, K.M.; Pumford, N.R. Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol. Sci. 2000, 54, 384-389.
29. Blossom, S.J.; Doss, J.C., Hennings, L.J.; Jernigan, S.; Melnyk, S.; James, S.J. Developmental exposure to trichloroethylene promotes CD4+ T cell differentiation and hyperactivity in association with oxidative stress and neurobehavioral deficits in MRL+/+ mice. Toxicol. Appl. Pharmacol. 2008, 231, 344-353.
30. Peden-Adams, M.M.; EuDaly, J.G.; Miller, J.G.; Keil, D.E.; Gilkeson, G.S. Lifetime exposure to trichloroethylene does not accelerate autoimmune disease in MRL +/+ mice. J. Environ. Sci. Health Pt. A 2008, 43, 1402-1409.
31. Pollard, K.M.; Pearson, D.L.; Hultman, P.; Deane, T.N.; Lindh, U.; Kono, D.H. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. Environ. Health Perspect. 2001, 109, 27-33.
32. Cooper, G.S.; Gilbert, K.M.; Greidinger, E.L.; James, J.A.; Pfau, J.C.; Reinlib, L.; Richardson, B.C.; Rose, N.R. Recent advances and opportunities in research on Lupus: Environmental influences and mechanisms of disease. Environ. Health Perspect. 2008, 116(6), 695-702.
33. Andrews, B.S.; Eisenburg, R.A.; Theofilopoulos, A.N.; Izui, S.; Wilson, C.B.; McConahey, P.J.; Murphy, E.D.; Roths, J.B.; Dixon, F.J. Spontaneous murine lupus-like syndromes. J. Exp. Med. 1978, 148, 1198-1215.
34. Luster, M.I.; Portier, C.; Pait, D.G.; White, K.L.Jr.; Gennings, C.; Munson, A.E.; Rosenthal, G.J. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fund. Appl. Toxicol. 1992, 18(2), 200-210.
35. Luster, M.I.; Munson, A.E.; Thomas, P.T.; Holsapple, M.P.; Fenters, J.D.; White, K.L. Jr.; Lauer, L.D.; Germolec, D.R.; Rosenthal, G.J.; Dean, J.H. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fund. Appl. Toxicol. 1988, 10(1), 2-19.
36. Barton, H.A.; Das, S. Alternatives for a risk assessment on chronic noncancer effects fromoral exposure to trichloroethylene. Reg. Tox. Pharmacol. 1996, 24(3), 269-285.
37. Holsapple, M.P.; White, K.L.; McCay, J.A.; Bradley, S.G.; Munson, A.E. An immunotoxicological evaluation of 4,4′-thiobis-(6-t-butylm-cresol) in female B6C3F1 mice. 2. Humoral and cell-mediated immunity, macrophage function, and host resistance. Fund. Appl. Toxicol. 1988, 10, 701-716.
38. Bryant, J.; Day, R.; Whiteside, T.L.; Herberman, R.B. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Meth. 1992, 146, 91-103.
39. Van Dam, A.P.; Meilof, J.F.; Van Den Brink, H.G.; Smeenk, R.J.T. Fine specificities of anti-nuclear antibodies in murine models of graft-versus-host disease. Clin. Exp. Immunol. 1990, 81, 31-38.
40. Pisetsky, D.S.; McCarty, G.A.; Peters, D.V. Mechanism of autoantibody production in autoimmune MRL mice. 1980, 152, 1302-1310.
41. Wright, P.F.; Thomas, W.D.; Stacey, N.H. Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicol. 1991, 70(2), 231-242.
42. Cauvi, D.M.; Cauvi, G.; Pollard K.M.; Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease. Arth. Rheum. 2007, 56(6), 1934-1944.
43. Lublin, D.M.; Atkinson, J.P. Decay-accelerating factor; biochemistry, molecular biology, and function. Annu. Rev. Immunol. 1989, 7, 35-58.
44. Pisetsky, D.S. Anti-DNA antibodies in systemic lupus erythematosus. Rheum. Dis. Clin. N. Amer. 1992, 18, 437-454.
45. Eilat, D. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol. Today 1985, 6, 123-127.
46. Mackworth-Young, C.; Schwartz, R.S. Autoantibodies to DNA. Crit. Rev. Immunol. 1988, 8, 147-173.
47. Swaak, A.J.; Groenwold, J; Bronsveld, W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann. Rheum. Dis. 1986, 45, 359-366.
48. Arbuckle, M.R.; James, J.A.; Kohlhase, K.F.; Rubertone, M.V.; Dennis, G.J.; Harley, J.B. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand. J. Immunol. 2001, 54(1-2), 211-219.
49. Sabbaga, J.; Roberto Peres, S,; Potocnjak, P.; Madaio, M.P. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur. J. Immunol. 1989, 19, 137-143.
50. Gilkeson G.S.; Pippen A.M.; Pisetsky D.S.; Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZBWF1 mice by immunization with bacterial DNA. J Clin. Invest. 1995, 95(3), 1398-1402.
51. Lake, R.A.; Morgan, A.; Henderson, B.; Staines, N.A. A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti-DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritis. Immunol. 1985, 54, 389-395.
52. Mustafa, A.; Holladay, S.D.; Goff, M.; Witonsky, S.G.; Kerr, R.; Reilly, C.M.; Sponenberg, D.P.; Gogal, R.M. Jr. An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicol. Appl. Pharmacol. 2008, 232(1), 51-59.